IRIS
BERGAMINI, ALICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.856
AS - Asia 2.766
NA - Nord America 2.675
SA - Sud America 506
Continente sconosciuto - Info sul continente non disponibili 267
AF - Africa 43
OC - Oceania 12
AN - Antartide 1
Totale 11.126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.531
RO - Romania 1.749
RU - Federazione Russa 1.700
SG - Singapore 935
CN - Cina 863
IT - Italia 579
BR - Brasile 414
HK - Hong Kong 253
VN - Vietnam 244
SE - Svezia 234
BD - Bangladesh 182
FR - Francia 124
DE - Germania 117
GB - Regno Unito 96
IN - India 80
CA - Canada 63
NL - Olanda 58
FI - Finlandia 50
MX - Messico 43
AR - Argentina 41
ES - Italia 38
JP - Giappone 35
PL - Polonia 32
TR - Turchia 30
ID - Indonesia 25
AT - Austria 20
ZA - Sudafrica 20
IE - Irlanda 18
IQ - Iraq 15
PK - Pakistan 15
CO - Colombia 13
MY - Malesia 13
LT - Lituania 11
CR - Costa Rica 10
EC - Ecuador 10
BE - Belgio 9
VE - Venezuela 8
JO - Giordania 7
MA - Marocco 7
PH - Filippine 7
UZ - Uzbekistan 7
AU - Australia 6
CL - Cile 6
IL - Israele 6
JM - Giamaica 6
PE - Perù 6
QA - Qatar 6
SA - Arabia Saudita 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
KR - Corea 5
NP - Nepal 5
TN - Tunisia 5
EG - Egitto 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
CH - Svizzera 3
HN - Honduras 3
IR - Iran 3
KZ - Kazakistan 3
PY - Paraguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
KW - Kuwait 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GP - Guadalupe 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
KY - Cayman, isole 1
LB - Libano 1
MD - Moldavia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 10.858
Salva come PNG Salva come JPEG
Città #
Singapore 467
Dallas 420
Moscow 357
Ashburn 330
San Jose 297
Hong Kong 252
Milan 161
Beijing 159
New York 147
Shanghai 141
Council Bluffs 128
Hefei 94
Los Angeles 91
Ho Chi Minh City 90
Lauterbourg 84
Hanoi 62
Santa Clara 54
Lawrence 46
Munich 46
Princeton 46
São Paulo 44
Boardman 42
Orem 39
Rome 37
Chennai 29
Warsaw 28
Denver 27
Tokyo 27
Turku 26
Bergamo 25
Vaprio d'Adda 25
Boston 24
Nuremberg 24
London 22
Brooklyn 20
Mexico City 20
Montreal 20
The Dalles 20
Amsterdam 19
Brescia 19
Houston 19
Manchester 19
Dublin 18
Haiphong 17
Helsinki 17
Toronto 17
Frankfurt am Main 16
Phoenix 16
Poplar 16
Seattle 16
Stockholm 16
Atlanta 15
Chicago 15
Columbus 15
Johannesburg 15
Omaha 14
Rio de Janeiro 14
St Petersburg 13
Buffalo 12
Florence 12
Naples 11
Rho 11
Turin 11
Belo Horizonte 10
Cesano Boscone 10
Guangzhou 10
Mumbai 10
Pune 10
Shenzhen 10
Tianjin 10
Ankara 9
Charlotte 9
Gatchina 9
Kuala Lumpur 9
Querétaro 9
Valencia 9
Bari 8
Istanbul 8
New Delhi 8
Paris 8
San Francisco 8
Vienna 8
Brussels 7
Lappeenranta 7
Philadelphia 7
San José 7
Tashkent 7
Xi'an 7
Biên Hòa 6
Brasília 6
Campinas 6
Cincinnati 6
Cleveland 6
Da Nang 6
Doha 6
Falkenstein 6
Fortaleza 6
Lima 6
Porto Alegre 6
Trieste 6
Totale 4.640
Salva come PNG Salva come JPEG
Nome #
Fertility sparing surgery in sex-cord stromal tumors: oncological and reproductive outcomes 410
Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study 386
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 370
Do stage and grade of malignancy impact fertility preservation in breast cancer patients? 368
Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin 352
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial 336
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 279
Additional value of uterine artery Doppler pulsatility index for ultrasound diagnosis of placental site trophoblastic tumor: prospective cohort study 254
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease 233
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses 228
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 198
Systemic delivery of cadherin 17–specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases 173
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 152
Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes 144
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 143
[Anti-angiogenic drugs and hypertension: from multidisciplinary collaboration to greater care] 136
Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN) 135
A Pictorial Ultrasound Essay of Gestational Trophoblastic Disease 135
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 133
A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. 128
A prospective, observational study of chemotherapy-induced ovarian damage on follicular reserve and maturation 127
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 125
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 124
A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach 124
Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group 121
Ovarian failure risk in post-pubertal patients with cancer: a prognostic model 120
Chemotherapy-Induced Nausea and Vomiting in Women With Gynecological Cancer: A Preliminary Single-Center Study Investigating Medical and Psychosocial Risk Factors 119
Chemotherapy-induced nausea in a sample of gynaecological cancer patients: assessment issues and personal risk factors evaluation 117
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 114
Psychological factors influencing emotional reactions to gestational trophoblastic disease: The role of coping mechanisms and illness perception 112
Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison 107
Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey 107
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 105
What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome 105
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 104
Inhibition of Phosphodiesterase 4 Enhances Clitoral and Vaginal Blood Flow Responses to Dorsal Clitoral Nerve Stimulation or PGE1 in Anesthetized Female Rats 103
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer 100
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 100
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 99
Contrast-enhanced ultrasound for ovary assessment in a murine model: preliminary findings on the protective role of a gonadotropin-releasing hormone analogue from chemotherapy-induced ovarian damage 96
Psychological aspects and fertility issues of GTD 95
Psychological Aspects Associated With Fertility Preservation in Oncology: An Exploratory Study 95
Does methotrexate (MTX) dosing in a 8-day MTX/FA regimen for the treatment of low-risk gestational trophoblastic neoplasia affect outcomes? The MITO-9 study 95
Factors Associated With a High Motivation to Undergo Fertility Preservation in Female Cancer Patients 94
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 89
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 88
Efficacy and safety of trabectedin for the treatment of advanced uterine or ovarian carcinosarcoma: Results of a phase II multicenter clinical trial (MITO-26) 88
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 87
Socio-demographic and psychological factors associated with quality of life of women undergoing chemotherapy treatment for gynecological cancer 86
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 84
Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors 82
Tumori del trofoblasto di origine gestazionale: impatto psicologico e ruolo dei meccanismi di difesa nel percorso di malattia 81
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 79
Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study 79
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 79
Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study 79
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 78
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis 78
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome 78
Carboplatin Use in Pregnancy for Stage IB3 Cervical Cancer: Case Report and Review of the Literature 77
Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence 77
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 76
Quality of life and chemotherapy: Predictive factors in a sample of gynaecological cancer patients 74
Gestational Trophoblastic Disease: the effect of mental representations on anxiety, depression, and infertility-related stress 73
Fertility sparing surgery in epithelial ovarian cancer in Italy: perceptions, practice, and main issues 73
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 72
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 71
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 70
Randomized controlled trial testing the efficacy of platinum-free interval prolongation in advanced ovarian cancer: The MITO-8,MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study 70
Hydatidiform mole: age-related clinical presentation and high rate of severe complications in older women 69
Reproductive Outcomes and Fertility Preservation Strategies in Women with Malignant Ovarian Germ Cell Tumors after Fertility Sparing Surgery 68
Role of Surgery in the Management of Hydatidiform Mole in Elderly Patients: A Single-Center Clinical Experience 68
Survival in clinical stage I endometrial cancer with single vs. multiple positive pelvic nodes: results of a multi-institutional Italian study 67
Correction to: A rare case of a giant arterio-venous fistula (AVF) following metastatic choriocarcinoma conditioning pulmonary embolism: multimodal transcatheter embolization using a simultaneous transarterial and transvenous approach (CVIR Endovascular, (2018), 1, 1, (30), 10.1186/s42155-018-0039-8) 66
Illness Perception in Gestational Trophoblastic Disease Patients: How Mental Representations Affect Anxiety, Depression, and Infertility-Related Stress 66
Perioperative Betamethasone Treatment Reduces Signs of Bladder Dysfunction in a Rat Model for Neurapraxia in Female Urogenital Surgery 66
Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors 64
Neoadjuvant chemotherapy in high-risk ovarian cancer patients: Role of age 64
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 63
Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience 63
Different Patterns of Disease Spread between Advanced-Stage Type i and II Epithelial Ovarian Cancer 62
Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis 61
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 61
Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time? 61
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 59
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study 59
Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy. 59
Ovarian endometrioma: what the patient needs 56
Mental Representations of Illness in Patients with Gestational Trophoblastic Disease: How Do Patients Perceive Their Condition? 54
Endometriosis-associated tumor at the inguinal site: report of a case diagnosed during pregnancy and literature review 53
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 53
Small Cell Carcinoma of the Ovary: Report of Three Cases of a Poor Prognosis Disease 52
Reproductive outcomes after gestational trophoblastic neoplasia. A comparison between single-agent and multiagent chemotherapy: Retrospective analysis from the MITO-9 group 52
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. 51
Reply to "Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: How Important Are Intrauterine Adhesions?". 49
Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy 49
Management of recurrent ovarian cancer: When platinum-based regimens are not a therapeutic option 49
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors 48
Fertility preservation in women with cervical cancer 48
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 35
Totale 11.064
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.196
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202238 0 1 1 7 0 1 7 7 3 4 7 0
2022/2023622 107 78 25 10 8 42 185 58 48 16 39 6
2023/2024500 17 23 62 54 57 89 11 59 10 18 26 74
2024/20253.377 141 35 64 51 89 130 1.955 162 259 158 139 194
2025/20266.112 455 335 511 764 520 191 541 440 1.466 308 258 323
2026/2027422 176 246 0 0 0 0 0 0 0 0 0 0
Totale 11.126